Pfizer Cutting Cost Of R&D Under Efficiency Program; Output To Double
Pfizer hopes to double output from its research and development operations while holding R&D costs in line with historic increases, CEO Hank McKinnell told investors July 20
Pfizer hopes to double output from its research and development operations while holding R&D costs in line with historic increases, CEO Hank McKinnell told investors July 20